Navigation Links
IOF-ESCEO congress will focus on advances in the management of musculoskeletal diseases
Date:1/14/2014

With the ageing of the population, health authorities all over the world are expecting a dramatic increase in the number of people suffering from chronic diseases of bone, muscle and joints. The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has become an important educational and research forum to help physicians meet the growing challenge posed by these serious diseases.

Held annually in Europe, the Congress is jointly organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). In 2014 the Congress will take place from April 2-5 in Seville, Spain.

Delegates will include leading researchers and health professionals from a broad spectrum of specializations, including rheumatology, endocrinology, orthopedics, radiology, general practice, and rehabilitation. CME accreditation is expected (application in process).

Accepted abstracts (submission possible until January 16, 2014) will be published in 'Osteoporosis International', one of the field's most highly cited peer-reviewed journals. Delegates who submit abstracts may be eligible for scholarships and awards: further information is available at http://www.wco-iof-esceo.org/awards


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Hot topics in translational bone research at IOF-ESCEO 3rd Pre-Clinical Symposium
2. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
3. Purdue professor to speak before Congress about nanotechnology in brain treatment research
4. ESMO 2012 Congress: A path for medical oncology innovations
5. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
6. International congress on behavior, animal husbandry and animal well-being in Vienna
7. 2016 International Congress of Entomology to be held in Orlando, Florida
8. Madidi conservationist wins award at World Conservation Congress
9. Noteworthy studies at the ESMO 2012 Congress
10. Majority of Americans doubt Congress and White House can avoid fiscal cliff
11. European Congress on Osteoporosis and Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Red Queen in Lewis Carroll,s Through the Looking ... National University of Singapore improved a 35-year-old ecology ... decades to millions of years. , The new ... incorporates the "Red Queen Effect," an evolutionary hypothesis ... which suggests that organisms must constantly increase their ...
(Date:7/30/2014)... protected and tended her eggs until they hatched 4.5 ... 2014 in the open-access journal PLOS ONE ... and colleagues. , Octopuses typically have a single reproductive ... take care of their fertilized eggs until they hatch. ... to 3 months, but little is known about the ...
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Deep-sea octopus has longest-known egg-brooding period 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2
... College Park, Md. (April 6, 2011) -- Most people experience X-ray ... tumor or blood clot. But in the lab of Dr. Quin ... a novel use of CT scanners as part of an agriculture ... a conveyor belt went little potted rice plants in an automated ...
... NY, April 6, 2011 The successful use ... and reduce the risk of neurological consequences following ... premier issue of Therapeutic Hypothermia and Temperature ... by Mary Ann Liebert, Inc. This groundbreaking new ...
... affects intake of caffeine, the most widely consumed stimulant in ... from the National Cancer Institute, Harvard School of Public Health, ... at Chapel Hill examined genetic variation across the entire genome ... in the open-access journal PLoS Genetics . ...
Cached Biology News:Seeing rice with X-rays may improve crop yields 2Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest 2Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest 3
(Date:7/30/2014)... , July 30, 2014 Regulus Therapeutics ... company leading the discovery and development of innovative medicines ... results and highlights for the quarter ended June 30, ... financial markets close. Regulus will host ... 2014, at 5:00 pm Eastern Daylight Time to discuss ...
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... today announced that the Companies intend to use a ... priority review voucher in connection with the Biologics License ... entitles the holder to designate a BLA for priority ... the filing date instead of the standard 10-month review. ...
(Date:7/30/2014)... 2014 W. R. Grace & ... the REVELERIS® Prep purification system , a ... and other researchers to perform both flash and ... , With the REVELERIS® Prep purification system, researchers ... modes with a simple touch of the screen, ...
(Date:7/30/2014)... 30, 2014  Decision Resources Group finds that ... in the United States ... penetration will be the level of savings achievable ... expected lower cost to patients. Payers plan to ... their pricing expectations in order to encourage physician ...
Breaking Biology Technology:Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Grace Launches New REVELERIS® Prep Purification System 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... today announced that it intends to file ... and Drug Administration,(FDA) for its innovative, anti-infective ... reviewing the data from our recently completed ...
... Life Science,Network has announced today that it will ... and measurable new life science business,for Michigan companies. ... the Michigan Virtual,Medical Device Company, LLC will launch ... the MichBio Expo annual convention in Lansing, Michigan.,MichBio ...
... Oct. 9 PARI Respiratory Equipment,s,breath-enhanced nebulizer, ... compressor,deliver Dey, L.P.,s new COPD medication, Perforomist ... is a subsidiary of Mylan Inc.,(NYSE: ... Solution is indicated for,long-term, twice-daily maintenance treatment ...
Cached Biology Technology:Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 2Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 3Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 4Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 5Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 6Michigan Life Science Network to Form Two New Virtual Companies 2Michigan Life Science Network to Form Two New Virtual Companies 3PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday 2PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday 3PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday 4
Mouse monoclonal antibody raised against a partial recombinant WDR5. NCBI Entrez Gene ID = WDR5...
... kit is a sample preparation kit for ... removal of detergents, phenolic compounds, salts, and ... dilute samples. The kit procedure involves a ... tissue or cells, plant leaves, E. coli, ...
... is intended for first-time users of the PROTEAN ... includes a protein sample and reagents sufficient to ... 17 cm, ten 11 cm, or sixteen 7 ... precast SDS-PAGE gels and gels stains are not ...
... Immunogen : Fusion protein ... 474-970 of human Mi-2 Formulation: ... NaCl, 0.035% sodium azide, containing ... evaluated by immunoblot on Hela ...
Biology Products: